- Home
- ZVRA vs SENS Comparison
ZVRA vs SENS Comparison
Compare ZVRA & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- SENS
- Stock Information
- Founded
- ZVRA 2006
- SENS 1996
- Country
- ZVRA United States
- SENS United States
- Employees
- ZVRA N/A
- SENS N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- ZVRA Health Care
- SENS Industrials
- Exchange
- ZVRA Nasdaq
- SENS Nasdaq
- Market Cap
- ZVRA 481.7M
- SENS 396.0M
- IPO Year
- ZVRA 2015
- SENS N/A
- Fundamental
- Price
- ZVRA $12.34
- SENS $0.49
- Analyst Decision
- ZVRA Strong Buy
- SENS Strong Buy
- Analyst Count
- ZVRA 9
- SENS 3
- Target Price
- ZVRA $23.25
- SENS $1.80
- AVG Volume (30 Days)
- ZVRA 1.0M
- SENS 6.3M
- Earning Date
- ZVRA 08-12-2025
- SENS 08-07-2025
- Dividend Yield
- ZVRA N/A
- SENS N/A
- EPS Growth
- ZVRA N/A
- SENS N/A
- EPS
- ZVRA N/A
- SENS N/A
- Revenue
- ZVRA $40,588,000.00
- SENS $23,682,000.00
- Revenue This Year
- ZVRA $292.31
- SENS $60.14
- Revenue Next Year
- ZVRA $78.65
- SENS $36.55
- P/E Ratio
- ZVRA N/A
- SENS N/A
- Revenue Growth
- ZVRA 46.47
- SENS 1.64
- 52 Week Low
- ZVRA $5.45
- SENS $0.25
- 52 Week High
- ZVRA $12.55
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- ZVRA 84.06
- SENS 45.60
- Support Level
- ZVRA $8.58
- SENS $0.48
- Resistance Level
- ZVRA $12.37
- SENS $0.51
- Average True Range (ATR)
- ZVRA 0.51
- SENS 0.02
- MACD
- ZVRA 0.31
- SENS 0.00
- Stochastic Oscillator
- ZVRA 98.47
- SENS 42.72
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.